Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Experts and medical practitioners have demanded the inclusion of the progressive neurodegenerative disease - Amyotrophic lateral sclerosis (ALS) - in the national rare disease policy to enable patients to get affordable care and treatment. The demand came ahead of the Global ALS/MND (motor neurone disease) Awareness Day, was observed on Wednesday.
The Niti Aayog is spearheading the initiative and is holding discussions with multiple stakeholders to understand the potential and challenges that the country faces in the manufacturing of VVMs.
Founded in the 1990s by Late Shyamsunder Taparia, Jaiprakash Taparia and family, Pregna is a contraception devices maker in the global IUD (intrauterine devices) space with a growing portfolio of reproductive and women’s health products. Pregna has a presence in over 140 countries and is the largest IUD manufacturer in the world. The company is led by Mukul Taparia.
Pharmacy chain MedPlus Health Services has launched a discount scheme on up to 500 off-patent therapeutic and chronic medicines under its brand, with reductions of between 50% and 80%. The Hyderabad-based firm plans to extend discounts to more than 800 products over the next three months, including prescription drugs for the treatment of conditions such as hypertension, diabetes and kidney ailments.
"When we acquired the company in 2019, our expansion and goal was a region of about 45 centres by 2023. So we are ahead of our goal. And we are already 62," said Vishal Bali, executive chairman of Asia Healthcare Holdings (AHH), the healthcare platform's promoter.